NRX Pharmaceuticals- Warrants (24/05/2026) Total Liabilities

As of the most recent data (March 2026), NRXPW shows a total liabilities of $26M. That compares with $33M in the prior-year period — down 21.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NRXPW's total liabilities is now $26M (was $33M) — a 21.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether NRX Pharmaceuticals- Warrants (24/05/2026) is outperforming or lagging.

Tracking NRXPW's total liabilities over time shows whether NRX Pharmaceuticals- Warrants (24/05/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $26M That compares with $33M in the prior-year period — down 21.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has NRX Pharmaceuticals- Warrants (24/05/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $26M) with ownership activity and broader fundamentals.

NRX Pharmaceuticals- Warrants (24/05/2026)'s total liabilities is $26M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.